Literature DB >> 22696929

CD200/CD200R paired potent inhibitory molecules regulating immune and inflammatory responses; Part I: CD200/CD200R structure, activation, and function.

Drahomíra Holmannová1, Martina Kolácková, Katerina Kondélková, Pavel Kunes, Jan Krejsek, Ctirad Andrýs.   

Abstract

CD200/CD200R are highly conserved type I paired membrane glycoproteins that belong to the Ig superfamily containing a two immunoglobulin-like domain (V, C). CD200 is broadly distributed in a variety of cell types, whereas CD200R is primarily expressed in myeloid and lymphoid cells. They fulfill multiple functions in regulating inflammation. The interaction between CD200/CD200R results in activation of the intracellular inhibitory pathway with RasGAP recruitment and thus contributes to effector cell inhibition. It was confirmed that the CD200R activation stimulates the differentiation ofT cells to the Treg subset, upregulates indoleamine 2,3-dioxygenase activity, modulates cytokine environment from a Thl to a Th2 pattern, and facilitates an antiinflammatory IL-10 and TGF-beta synthesis. CD200/CD200R are required for maintaining self-tolerance. Many studies have demonstrated the importance of CD200 in controlling autoimmunity, inflammation, the development and spread of cancer, hypersensitivity, and spontaneous fetal loss.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22696929     DOI: 10.14712/18059694.2015.68

Source DB:  PubMed          Journal:  Acta Medica (Hradec Kralove)        ISSN: 1211-4286


  27 in total

1.  Upregulated CD200 in pre-retinal proliferative fibrovascular membranes of proliferative diabetic retinopathy patients and its correlation with vascular endothelial growth factor.

Authors:  Yaguang Hu; Anming Xie; Qiaochu Cheng
Journal:  Inflamm Res       Date:  2019-10-14       Impact factor: 4.575

2.  Peripheral Blood Monocyte Tolerance Alleviates Intraperitoneal Lipopolysaccharides-Induced Neuroinflammation in Rats Via Upregulating the CD200R Expression.

Authors:  Liping Xia; Xin Xie; Yang Liu; Xiaoguang Luo
Journal:  Neurochem Res       Date:  2017-06-29       Impact factor: 3.996

3.  Anti-angiogenic and anti-inflammatory effects of CD200-CD200R1 axis in oxygen-induced retinopathy mice model.

Authors:  Yaguang Hu; Ting Wei; Shan Gao; Qiaochu Cheng
Journal:  Inflamm Res       Date:  2019-08-23       Impact factor: 4.575

4.  Reduced CD200 expression is associated with altered Th1/Th2 cytokine production in placental trophoblasts from preeclampsia.

Authors:  Jie Xu; Yang Gu; Jingxia Sun; Hui Zhu; David F Lewis; Yuping Wang
Journal:  Am J Reprod Immunol       Date:  2017-09-20       Impact factor: 3.886

5.  Expression of CD200R1 and its Ligand CD200 on T-helper Lymphocytes of Pediatric Patients with Ulcerative Colitis and Crohn's Disease.

Authors:  Mohamed F Elshal; Alia M Aldahlawi; Omar I Saadah; J Philip Mccoy
Journal:  Clin Lab       Date:  2016-08-01       Impact factor: 1.138

Review 6.  The Role of the Immune System in the Development of Endometriosis.

Authors:  Monika Abramiuk; Ewelina Grywalska; Paulina Małkowska; Olga Sierawska; Rafał Hrynkiewicz; Paulina Niedźwiedzka-Rystwej
Journal:  Cells       Date:  2022-06-25       Impact factor: 7.666

7.  CXCL8, IL-1β and sCD200 are pro-inflammatory cytokines and their levels increase in the circulation of breast carcinoma patients.

Authors:  Betul Celik; Arzu Didem Yalcin; Gizem Esra Genc; Tangul Bulut; Sibel Kuloglu Genc; Saadet Gumuslu
Journal:  Biomed Rep       Date:  2016-06-30

8.  Understanding the neurobiology of CD200 and the CD200 receptor: a therapeutic target for controlling inflammation in human brains?

Authors:  Douglas G Walker; Lih-Fen Lue
Journal:  Future Neurol       Date:  2013-05

9.  Plasmacytoid dendritic cells and type 1 interferon promote peripheral expansion of forkhead box protein 3(+) regulatory T cells specific for the ubiquitous RNA-binding nuclear antigen La/Sjögren's syndrome (SS)-B.

Authors:  Z-J Pan; C G Horton; C Lawrence; A D Farris
Journal:  Clin Exp Immunol       Date:  2016-08-03       Impact factor: 4.330

10.  CD200 Immune-Checkpoint Peptide Elicits an Anti-glioma Response Through the DAP10 Signaling Pathway.

Authors:  Elisabet Ampudia-Mesias; Francisco Puerta-Martinez; Miurel Bridges; David Zellmer; Andrew Janeiro; Matt Strokes; Yuk Y Sham; Ayman Taher; Maria G Castro; Christopher L Moertel; G Elizabeth Pluhar; Michael R Olin
Journal:  Neurotherapeutics       Date:  2021-04-07       Impact factor: 6.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.